Proteomic meta-study harmonization, mechanotyping and drug repurposing candidate prediction with ProHarMeD

Abstract Proteomics technologies, which include a diverse range of approaches such as mass spectrometry-based, array-based, and others, are key technologies for the identification of biomarkers and disease mechanisms, referred to as mechanotyping. Despite over 15,000 published studies in 2022 alone,...

Full description

Bibliographic Details
Main Authors: Klaudia Adamowicz, Lis Arend, Andreas Maier, Johannes R. Schmidt, Bernhard Kuster, Olga Tsoy, Olga Zolotareva, Jan Baumbach, Tanja Laske
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:npj Systems Biology and Applications
Online Access:https://doi.org/10.1038/s41540-023-00311-7